Gordon Research Conferences
Meeting Details
Search:
  GO

Cancer Nanotechnology (GRS)
Gordon-Kenan Research Seminar

Science, Engineering, and Translational Research in Cancer Nanotechnology

Dates

June 17-18, 2017

Location

Mount Snow
West Dover, VT

Organizers

Chairs:
Alexander A. Kislukhin & Adriana Avila

Meeting Description

The Gordon Research Seminar on Cancer Nanotechnology, held for the first time in 2017, will bring together graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.

Cancer nanotechnology is a complex discipline that is fueled by the latest advances in basic chemistry and biology. Translating fundamental science and innovative engineering solutions into new clinical options requires a coordinated effort of diverse group of of researchers. This unique forum will feature outstanding research by early career scientists across the continuum of cancer research.

Related Meeting

This GRS was held in conjunction with the "Cancer Nanotechnology" Gordon Research Conference (GRC). Refer to the associated GRC program page for more information.

Contributors

Meeting Program

Saturday
2:00 pm - 5:00 pmArrival and Check-in
3:30 pm - 3:45 pmIntroductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair
3:45 pm - 4:30 pmNew Delivery Strategies for Anticancer Therapies
Discussion Leader: Adriana Avila (Auburn University, USA)
3:45 pm - 4:05 pmElizabeth Wayne (University of North Carolina at Chapel Hill, USA)
"Macrophage-Mediated Gene Delivery to the Tumor Microenvironment"
4:05 pm - 4:10 pmDiscussion
4:10 pm - 4:25 pmNitzan Krinsky (Technion - Israel Institute of Technology, Israel)
"Protein-Producing Particles for On-Site Drug Delivery"
4:25 pm - 4:30 pmDiscussion
4:30 pm - 6:00 pmPoster Session
6:00 pmDinner
7:30 pm - 9:30 pmNew Anticancer Nanomaterials / Keynote Session: Spherical Nucleic Acids as a Powerful New Platform to Develop Cancer Vaccines
Discussion Leader: Emily Day (University of Delaware, USA)
7:30 pm - 7:50 pmSumit Dadhwal (University of Otago, New Zealand)
"Bioorthogonal Triggered Responsive Polymersomes for Anticancer Drug Delivery"
7:50 pm - 8:00 pmDiscussion
8:00 pm - 8:20 pmJulius Mueller (Max Planck Institute for Polymer Research, Germany)
"Controlling the Protein Corona of Nanoparticles by Coating Their Surface with Tunable Surfactants"
8:20 pm - 8:30 pmDiscussion
8:30 pm - 9:10 pmChad Mirkin (Northwestern University, USA)
"Spherical Nucleic Acids as a Powerful New Platform to Develop Cancer Vaccines"
9:10 pm - 9:30 pmDiscussion
Sunday
7:30 am - 8:30 amBreakfast
9:00 am - 11:00 amCancer Nanomedicines: From Bench to Clinic
Discussion Leader: Martin Purschke (Massachusetts General Hospital, USA)
9:00 am - 9:20 amAnna Brown (Oregon State University, USA)
"Radiation Dose Enhancing Nanoparticles: Designing for Efficacy"
9:20 am - 9:30 amDiscussion
9:30 am - 9:50 amDesiree Van Haute (U.S. Food and Drug Administration, USA)
"Development of Robust Asymmetric Field Flow Fractionation Methods for the Comparison of Innovator and Generic Liposomal Nanomedicines in Oncology"
9:50 am - 10:00 amDiscussion
10:00 am - 10:20 amBrynn Olden (University of Washington, USA)
"Cationic Polymers for Non-Viral Gene Delivery to Primary Human T Cells"
10:20 am - 10:30 amDiscussion
10:30 am - 10:50 amZvi Yaari (Technion - Israel Institute of Technology, Israel)
"Theranostic Barcoded Nanoparticles for Personalized Cancer Medicine"
10:50 am - 11:00 amDiscussion
11:00 am - 12:30 pmPoster Session

Coffee will be served in the poster area from 11:00 am - 11:30 am
12:30 pmLunch
1:30 pm - 2:30 pmVisualization and Modeling of Disease and Treatment Outcomes
Discussion Leader: Alexander Kislukhin (SomaLogic, USA)
1:30 pm - 1:50 pmStefan Wilhelm (University of Toronto, Canada)
"Analysis of Nanoparticle Targeting to Solid Tumors"
1:50 pm - 2:00 pmDiscussion
2:00 pm - 2:20 pmRebeca Romero Aburto (University of Texas MD Anderson Cancer Center, USA)
"Contrast Agent Development and Validation for In-Vivo Early Cancer Detection Using Magnetic Relaxometry"
2:20 pm - 2:30 pmDiscussion
2:30 pm - 3:00 pmEvaluation Period
Fill in GRS Evaluation Forms
3:00 pmSeminar Concludes

Funding for this conference was made possible (in part) by 1R13CA213845-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
© 2017 Gordon Research Conferences Search | Contact | Terms of Use | Privacy Policy | Follow us: Facebook Twitter